Syrian Information Minister: Turkish Foreign Minister, Intelligence Minister and Qatar National Security Minister met with Syrian opposition leader Shara and caretaker Prime Minister Bashir in Damascus.The forecast of the European Central Bank assumes that the exchange rate of the euro against the US dollar will be 1.08 in 2024 and 1.06 in 2025, 2026 and 2027.Trump: If Kennedy Jr. takes action, he will have a "big discussion" on ending the children's vaccination program.
Trump: For me, the stock market is everything and very important.According to statistics, on December 12th, as of press time, five A-share listed companies including Alaide, Zhongzhong Technology, Yiwang Yichuang, Crystal Optoelectronics and Decai Co., Ltd. disclosed their holdings.Market News: Ibrahim Karin, Director of Turkish Intelligence Agency, has arrived in the Syrian capital.
Trump: For me, the stock market is everything and very important.Central Economic Work Conference: Support major economic provinces to take the lead, and encourage other regions to develop their strengths according to local conditions. The Central Economic Work Conference was held in Beijing on December 11th and 12th. The meeting proposed to strengthen the implementation of regional strategies and enhance the vitality of regional development. Give play to the superposition effect of regional coordinated development strategy, regional major strategy and main functional area strategy, and actively cultivate new growth poles. Enhance the innovation ability and radiation-driven role of areas with economic development advantages. Support major economic provinces to take the lead, and encourage other regions to develop their strengths according to local conditions. Deepen industrial cooperation in the eastern, central, western and northeastern regions, and vigorously develop the marine economy and the Bay Area economy. (Xinhua News Agency)Baiyang Pharmaceutical Group signed an agreement with Peking University Hospital. On December 12, Baiyang Pharmaceutical Group signed a cooperation agreement with Peking University No.1 Hospital, and obtained the exclusive right to patent, clinical development and registration, production and marketing of "targeted integrin small molecule inhibitor" in Peking University Hospital.
Strategy guide
12-13
Strategy guide
12-13
Strategy guide